Description
Wiseguyreports.Com Adds “Radiopharmaceuticals -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database
Radiopharmaceuticals are medicinal formulations that contain radioisotopes. They are composed of a radioisotope and a carrier molecule and are generally molded according to the physiological function of the targeted organ. After administration, the radioisotope emits gamma radiation, which is used for either therapeutic or diagnostic purposes. In recent years, the market for diagnostic radiopharmaceuticals has shown growth due to the increasing incidence of cancer and neurological and cardiac diseases and the development of better imaging techniques for conditions such as Alzheimer’s disease. Therapeutic radiopharmaceuticals account for a small proportion of the global radiopharmaceuticals market. However, the market for therapeutic
radiop-harmaceuticals is expected to experience strong growth in the coming years due to increased demand.
R&D spending, along with increasing competition, expiration of related patent and new technologies, are giving a new direction to the market. Technology advancements, new product launches and changing lifestyles will influence future market growth. This study discusses how these factors will affect the market.
Companies’ acquisition strategies and collaborations are also covered in this report. Further, the report discusses the strengths and weaknesses of each
radiopharmaceuticals type in light of new technologies, growing competition and changing customer needs.
SCOPE OF THE STUDY
This report focuses on the global market for radiopharmaceutical products. Radiopharmaceuticals provide actual mapping of the physiological functions and metabolic activity of organs. They provide highly specific information on organ function and dysfunction. Radiopharmaceuticals can also be used in radiotherapy to destroy dysfunctional cells.
In this report, BCC Research analyzes each global market in terms of applications, regulatory environment, new products and advancements, market projections and market shares. The geographical regions covered in the report are North America and Europe and an emerging markets category. The emerging markets category covers countries that include India, China, Japan, Korea, Taiwan, Africa, Australia, New Zealand and Canada.
This report also includes an analysis of relevant patent and comprehensive profiles of leading companies in the radiopharmaceuticals industry. Some of the major global players in the radiopharmaceuticals industry are Advanced Medical Isotope Corp., Advanced Accelerator Applications SA, Bayer AG (Bayer HealthCare Pharmaceuticals Inc.), Bracco S.p.A. (Bracco Imaging S.p.A.), Cardinal Health Inc., Eli Lilly and Co., Fujifilm RI Pharma Co. Ltd. (Fujifilm Corp.), General Electric Co. (GE Healthcare), Jubilant Life Sciences (Jubilant DraxImage Inc.), Lantheus Holdings Inc. (Lantheus Medical Imaging Inc.), Mallinckrodt PLC, Navidea Biopharmaceuticals Inc., Noridon Inc., Piramal Enterprises Ltd. (Piramal Imaging SA), Siemens AG (Siemens PETNET Solutions Inc.) and Triad Isotopes Inc.
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3375388-radiopharmaceuticals-technologies-and-global-markets
Report Scope:
This report focuses on the global market for radiopharmaceutical products. Radiopharmaceuticals provide actual mapping of the physiological functions and metabolic activity of organs. They provide highly specific information on organ function and dysfunction. Radiopharmaceuticals can also be used in radiotherapy to destroy dysfunctional cells.
In this report, BCC Research analyzes each global market in terms of applications, regulatory environment, new products and advancements, market projections and market shares. The geographical regions covered in the report are North America and Europe and an emerging markets category. The emerging markets category covers countries that include India, China, Japan, Korea, Taiwan, Africa, Australia, New Zealand and Canada.
This report also includes an analysis of relevant patent and comprehensive profiles of leading companies in the radiopharmaceuticals industry. Some of the major global players in the radiopharmaceuticals industry are Advanced Medical Isotope Corp., Advanced Accelerator Applications SA, Bayer AG (Bayer HealthCare Pharmaceuticals Inc.), Bracco S.p.A. (Bracco Imaging S.p.A.), Cardinal Health Inc., Eli Lilly and Co., Fujifilm RI Pharma Co. Ltd. (Fujifilm Corp.), General Electric Co. (GE Healthcare), Jubilant Life Sciences (Jubilant DraxImage Inc.), Lantheus Holdings Inc. (Lantheus Medical Imaging Inc.), Mallinckrodt PLC, Navidea Biopharmaceuticals Inc., Noridon Inc., Piramal Enterprises Ltd. (Piramal Imaging SA), Siemens AG (Siemens PETNET Solutions Inc.) and Triad Isotopes Inc.
Report Includes:
– An overview of the global market for radiopharmaceuticals and related technologies.
– Analyses of global market trends, with data from 2014 and 2015, 2016, and projections of compound annual growth rates (CAGRs) through 2021.
– Information on how radiopharmaceuticals are used to diagnose cancer, tumors, brain diseases, bone diseases, bone marrow diseases, colorectal disease, kidney diseases, liver diseases, lung diseases, and many others.
– Details concerning the regulatory environment and the impacts of government on the market.
– Analysis of the market’s dynamics, specifically growth drivers, restraints, and opportunities
– Profiles of leading companies in the industry.
Table of Contents
Chapter 1 INTRODUCTION
Chapter 2 EXECUTIVE SUMMARY
Chapter 3 OVERVIEW
Chapter 4 REGULATORY ASPECTS
Chapter 5 NEW DEVELOPMENTS
Chapter 6 MARKET ANALYSIS
Chapter 7 INDUSTRY STRUCTURE
Chapter 8 PATENT ANALYSIS
Chapter 9 CURRENT SITUATION
Chapter 10 COMPANY PROFILES
Chapter 11 ABBREVIATIONS
Leave a Query @ https://www.wiseguyreports.com/check-discount/3375388-radiopharmaceuticals-technologies-and-global-markets
Continued…
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)
Your information will never be shared with any third party.